Related Experiment Video

Updated: Jul 31, 2026

A Novel High-resolution In vivo Imaging Technique to Study the Dynamic Response of Intracranial Structures to Tumor Growth and Therapeutics
12:09

A Novel High-resolution In vivo Imaging Technique to Study the Dynamic Response of Intracranial Structures to Tumor Growth and Therapeutics

Published on: June 16, 2013

Therapeutic strategies that selectively target and disrupt established tumor vasculature

Dietmar W Siemann1

  • 1Department of Radiation Oncology, Shands Cancer Center, 2000 SW Archer Road, Gainesville, FL 32610, USA. siemadw@ufl.edu

Hematology/Oncology Clinics of North America
|October 12, 2004
PubMed

Insights

This study explores therapeutic strategies designed to selectively target and disrupt established tumor vasculature. These approaches aim to inhibit tumor growth by attacking its blood supply.

Area of Science:

  • Oncology
  • Vascular Biology
  • Cancer Therapeutics

Background:

  • Tumor growth and metastasis are critically dependent on a dedicated blood supply.
  • Established tumor vasculature differs significantly from normal vasculature, presenting unique therapeutic targets.
  • Disrupting tumor vasculature can impede nutrient and oxygen delivery, leading to tumor regression.

Purpose of the Study:

  • To review and discuss therapeutic strategies that selectively target and disrupt established tumor vasculature.
  • To highlight the mechanisms of action for different anti-vasculature therapies.
  • To assess the potential of these strategies in cancer treatment.

Main Methods:

  • Review of preclinical and clinical studies on anti-angiogenic and vascular-disrupting agents.
  • Analysis of therapeutic approaches targeting endothelial cells, pericytes, and the tumor microenvironment.
  • Discussion of drug delivery systems and combination therapies.

Main Results:

  • Various therapeutic strategies effectively target tumor vasculature.
  • Selective disruption of tumor blood vessels can lead to significant tumor growth inhibition.
  • Combination therapies show enhanced efficacy in preclinical models.

Conclusions:

  • Targeting tumor vasculature is a promising therapeutic strategy in oncology.
  • Further research is needed to optimize existing therapies and develop novel approaches.
  • Selective disruption of tumor vasculature holds potential for improving cancer patient outcomes.

More Related Videos

Intravital Microscopy of Tumor-associated Vasculature Using Advanced Dorsal Skinfold Window Chambers on Transgenic Fluorescent Mice08:52

Intravital Microscopy of Tumor-associated Vasculature Using Advanced Dorsal Skinfold Window Chambers on Transgenic Fluorescent Mice

Published on: January 19, 2018

Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis09:33

Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis

Published on: March 20, 2026

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...